NEW YORK (GenomeWeb) – BioMérieux said today that its second quarter sales grew 18 percent, as the installed base of its FilmArray platform expanded to nearly 1,900 instruments.

For the three months ended June 30, the Marcy L'Etoile, France-based in vitro diagnostics firm reported revenues of €485.3 million ($526.6 million) compared to €409.9 million in Q2 2014.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.